GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 1 filers reported holding GILEAD SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $67,867,000 | -7.9% | 16,500,000 | 0.0% | 0.30% | -5.6% |
Q4 2015 | $73,724,000 | +1.8% | 16,500,000 | -2.4% | 0.32% | +8.4% |
Q3 2015 | $72,448,000 | -17.8% | 16,900,000 | -1.2% | 0.30% | -15.9% |
Q2 2015 | $88,172,000 | +19.7% | 17,100,000 | 0.0% | 0.35% | +16.1% |
Q1 2015 | $73,669,000 | -3.8% | 17,100,000 | -7.6% | 0.30% | -1.0% |
Q4 2014 | $76,567,000 | -11.4% | 18,500,000 | 0.0% | 0.31% | -16.8% |
Q3 2014 | $86,384,000 | +27.4% | 18,500,000 | -0.5% | 0.37% | +30.9% |
Q2 2014 | $67,797,000 | +21.1% | 18,600,000 | +3.3% | 0.28% | +15.6% |
Q1 2014 | $55,991,000 | -5.7% | 18,000,000 | 0.0% | 0.24% | -8.3% |
Q4 2013 | $59,366,000 | +19.1% | 18,000,000 | 0.0% | 0.27% | +8.6% |
Q3 2013 | $49,838,000 | +22.3% | 18,000,000 | 0.0% | 0.24% | +13.4% |
Q2 2013 | $40,736,000 | – | 18,000,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INCOME RESEARCH & MANAGEMENT | 9,376,000 | $40,393,000 | 6.90% |
MACKAY SHIELDS LLC | 12,148,000 | $52,358,000 | 2.77% |
DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $6,465,000 | 2.53% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,710,000 | 2.53% |
SSI INVESTMENT MANAGEMENT LLC | 4,620,000 | $19,905,000 | 1.88% |
CNO Financial Group, Inc. | 500,000 | $2,154,000 | 0.91% |
ADVENT CAPITAL MANAGEMENT /DE/ | 13,789,000 | $59,376,000 | 0.86% |
Man Investments (CH) AG | 400,000 | $1,724,000 | 0.83% |
Lombard Odier Asset Management (Europe) Ltd | 2,380,000 | $10,242,000 | 0.80% |
CQS Cayman LP | 3,750,000 | $16,252,000 | 0.76% |